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Abstract
Purpose: To evaluate the corneal endothelial cell density and 
polymegathism after laser assisted keratomileusis with mitomycin C.
Patients and Methods: One hundred and three eyes from 52 patients un-
dergoing laser assisted sub-epithelial keratomileusis using mitomycin-C 
0.02 % for 30 seconds entered this study. Specular microscopy was utilized 
to study the corneal endothelial cells before and one year after the surgery to 
evaluate the endothelial cell density and polymegathism. The corneal thick-
ness was measured before and one year after the surgery.
Results: The mean endothelial cell density before surgery was 
2870 ± 368 /mm2, which changed to 2828 ± 300 /mm2 one year after 
the surgery (P = 0.182). Endothelial cell size variation coefficient 
was 24 ± 7 before the surgery, which changed to 25 ± 7 one year 
after the surgery (P = 0.039). The average stromal ablation dept was 
65 micron (22 to 131 micron) and the remaining corneal thickness 
one year after the surgery was 488 ± 42 micron (405 to 567 micron) 
(P < 0.001).
Conclusion: Using mitomycin C (0, 02 % for 30 seconds) during 
the laser assisted sub-epithelial keratomileusis did not significantly 
change the corneal endothelial cell density one year after the surgery 
but the change in polymegathism was significant.
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Introduction
Laser-Assisted in Situ Keratomileusis (LASIK) 
is a widespread surgical procedure because of its 
advantages such as, less pain, rapid visual reha-
bilitation and lower incidence of complications (1). 
A modification of this method called Laser-Assisted 
Subepithelial Keratectomy (LASEK) was first 
introduced by Massimo Camellin (2). This sur-
gical procedure is used to treat nearsightedness, 
farsightedness and astigmatism and is also an 
effective technique to correct refractive errors in 
eyes with high myopia, thin corneas and damaged 
retina. It reduces some complications of LASIK 
surgery like corneal ectasia (3). At the end of 
this procedure, the corneal epithelium is cov-
ered again by the epithelium. This leads to better 
wound healing, protects the bare stroma from tear 
inflammatory cells and reduces the corneal haze 
and postoperative pain which helps to maintain 
the stability of the cornea (3). In addition, because 
there is no incision in the cornea it maintains the 
corneal stability like photorefractive keratectomy 
(PRK) and by eliminating the flap complications of 
LASIK it will be possible to treat patients with thin 
corneas, as well as patients with large pupils (3-5).
In LASEK the surgeon tries to keep the corneal 
epithelium to reduce the corneal opacity (haze), 
which is a major complication after application of 
PRK, but corneal opacity is still a main complication 
of this procedure (2,3).
In LASEK and PRK, mitomycin-C is used as a 
topical treatment to help preventing the corne-
al opacity (6-9). Animal models have shown that 
mitomycin-C can cause suppression of the ac-
tivity of keratocytes and fibroblasts and prolong 
keratocytes apoptotic process after LASEK and 
PRK which can explain its effect on corneal 
opacity (9-17). Although many clinical studies have 
indicated the safety of the use of mitomycin-C 
after LASEK and PRK surgery (18-21), however the 
issue of toxicity of mitomycin-C on endothelial 
cells remains controversial. Some studies, have 
indicated significant changes in corneal endothelial 
cells after application of mitomycin-C (22,23). They 
have also indicated that the toxicity of mitomycin-C 
on endothelial cells depends on the length of time or 
the concentrations of the drug (24).
Since there are different reports considering the 
rate of change of endothelial cells after photore-
fractive surgery with mitomycin-C, this study was 
performed to evaluate the effects of mitomycin-C 
on endothelial cell density and coefficient of 




In a retrospective study, 103 eyes of 52 patients 
who underwent LASEK surgery for myopia and 
myopic astigmatism correction with mitomycin-C 
were evaluated. All patients were from Negah Eye 
hospital, Tehran, Iran. Patients did not wear soft 
contact lenses for one week or hard contact lens 
or 6 to 8 weeks before the surgery. Patients with 
any systemic disease or a history of system-
ic or topical medications with an impact on 
the endothelium of the cornea were excluded 
from the study.
Preoperative examination
Preoperative examination included the evaluation 
of uncorrected visual acuity (UCVA) and best 
corrected visual acuity (BCVA) using Snellen 
chart (Auto chart projector Nidek CP 670), 
manifest and cycloplegic refraction, slit lamp 
examination, measurement of eye pressure using 
tonometry (Goldmann applanation), and dilated 
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fundus examination. In all patients, corneal topog-
raphy was performed to evaluate the thickness and 
curvature of the cornea using Orbscan II (Bausch 
& Lomb’s Orbscan IIz) to ensure there is no indica-
tion of keratoconus. Study on endothelial cells 
was performed using a non-contact specular 
microscopy system (Topcon SP2000P, Tokyo, 
Japan).
Postoperative visits
Eyes were evaluated one to four days after the 
surgery, in the third and eighth weeks, as well 
as six and twelve months after the surgery. 
Postoperative examination included UCVA and 
BCVA measurements, refraction measurement, 
examination of the anterior segment using slit 
lamp, measurement of the corneal thickness using 
Orbscan II and measurement of the eye pressure. 
Calculation of the corneal endothelial cell density 
and coefficient of variation of endothelial cells using 
non-contact specular microscopy was performed one 
year after the LASEK surgery.
Assessment of  endothelial cells
To evaluate changes in endothelial cells all patients 
were examined before and one year after LASEK 
procedure. Corneal endothelial cell density and size 
variation coefficient was calculated before and one 
year after the surgery by a qualified optometrist and 
using non-contact specular microscopy (Topcon 
SP2000P, Tokyo, Japan). This device uses frame 
method, to automatically select 20 endothelial cells 
and provides an estimate for the total endothelial 
density. The endothelial cell density, the coefficient 
of variation of corneal endothelial cells, the average 
area of endothelial cells, and central corneal 
thickness was investigated. During the specular 
microscopy patients were asked to look directly 
towards the central objective to ensure that the 
center of the cornea is examined.
LASEK surgery technique
After dropping a few drops of tetracaine 5.0 percent 
(Sina Darou, Tehran, Iran), 20 % alcohol diluted 
with BSS solution was applied for 20 seconds in a 
standard 8 mm corneal marker to the center of the 
cornea. The eye was rinsed with BSS solution and 
the corneal epithelium was removed using a hock-
ey knife. The corneal ablation was performed using 
a Technolas machine (Technolas 217z100, Bausch 
& Lomb Surgical Rochester, NY) with front wave 
method by two experienced surgeons. For all patients, 
a sponge soaked in Mitomycin-C 0.02 %, was applied 
for 30 seconds in the laser area. Using the sponge pre-
vents the release of the drug into the surrounding tis-
sue. At the end of the procedure the eye and flap 
were rinsed again with 50 ml of cold BSS and the 
flap was returned slowly to its location. A bandage 
contact lens (Ciba Vision, Night and Day ®) was 
placed and a drop of chloramphenicol and a drop 
of betamethasone was applied to end the procedure.
From day one after surgery chloramphenicol drops 
were used every 6 hours for one week. Also 
fluorometholone (FML) drop 1 percent was applied 
every 6 hours for one month, every 8 hours in the 
second month, and every 12 hours in the third 
month. Diclofenac was applied every 12 hours in 
the first three days if the patient complained of 
pain. Contact lens bandage was removed after 
complete epithelium recovery. 
Statistical Analysis
To describe the data, average (median and inter-
quartile range), standard deviation, frequency and 
percentage were used. for comparison of endothelial 
cells before and after the intervention paired T-test 
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was used. SPSS software (Version 20. Armonk, 
NY: IBM Corp.) was used for statistical anal-
ysis. P values less than 0.05 were considered 
statistically significant.
Results
One hundred and three eyes from 52 patients 
who underwent LASEK using mitomycin-C for 
were included in the study. The average age of 
patients was 27 years with a range of 19 to 48 
years, with 17 patients (69/32 %) being male and 
35 patients (30/67 %) being female. The degree 
of myopia, astigmatism, spherical equivalent, 
corneal thickness and corneal thickness before 
and after surgery is displayed in table1.








 65 13122Ablation Dept (Micron)
547 616473Preoperative Corneal 
Thickness (Micron) 
488  567405Postoperative Corneal 
Thickness (Micron)
correction of myopia and myopic astigmatism 
The average central corneal thickness was 547 ± 37 
micrometers before the surgery and 482 ± 42 mi-
crometers after the surgery (P = 0.001) (Table 2). 
The average corneal endothelial cell density was 
2870 ± 368 before the surgery, and 2828 ± 300 
one year after surgery (P = 0.182) (Table 2). Pre-
operative corneal endothelial cell size variation 
coefficient was 24 ± 7 percent before the surgery, 
and 25 ± 7 percent one year after the surgery 
(P = 0.039) (Table 2). 
Table 2: Comparison of corneal thickness and corneal




 < 0.001488 ± 42547 ± 32Central Corneal 
Thickness
0.432358 ± 39354 ± 47 
Mean Corneal Endothe-
lial Cell Size (Square mi-
crometer)
0.1822828 ± 3002870 ± 368
Corneal Endothelial 
Cell Density
0.03925 ± 724 ± 7
Corneal Endothelial 
Cell Size Variation 
Coefficient (%)
Furthermore, the mean preoperative endothelial 
cell area was 354 ± 47 square micrometers before 
the surgery and 358 ± 39 square micrometers after 
the surgery (P = 0.432) (Table 2). No intraoperative 
complications such as defects in the repair of 
corneal epithelium or keratitis after the surgery 
was observed. Also no significant corneal opacity 
was observed in any of the patients.
Discussion
It has been reported that intraoperative use 
of direct mitomycin-C in LASEK and PRK 
procedures remarkably reduces the corneal 
opacity (9,13,14,25). Concerns about the compli-
cations after mitomycin-C usage in treatment of 
pterygium (26,27), glaucoma (28) and ocular surface 
neoplasia (29) have been raised. Although these 
complications have not been reported after its 
usage in LASEK and PRK procedures (30), however, 
studying the subclinical toxic effects of mitomycin-C 
on cornea is needed. Mitomycin-C has long-term 
effects on cells that have a high proliferation 
rate like keratocytes and corneal epithelial cells, 
however, there is also a possibility of damage to 
nonproliferative cells like endothelial cells (20,30). 
In studies on rabbits it has been demonstrated 
that mitomycin-C causes corneal edema and 
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endothelial cell apoptosis which is related to its 
concentration and corneal contact time (30). The 
effects of mitomycin-C on human cornea may be 
different because rabbit corneal endothelial cells 
have a high degree of proliferation compared to 
human corneal endothelial cells.
There is no report of human corneal edema after 
corneal refractive surgery using mitomycin-C 
(0.02 %), so the possibility of severe damage to 
the endothelial cells is unlikely (30). 
In our study, application of mitomycin-C (0.02 %) 
caused no significant change in the number of en-
dothelial cells one year after LASEK surgery but 
other studies have reported conflicting results. 
Lee et al., did not find a statistically significant 
change in the number of endothelial cells 3, 6 and 
16 months after PRK surgery using mitomycin-C 
(0.02 %) for 30 seconds (31). Also Goldsberry et 
al., (21) did not find a significant change in the 
number and morphology of corneal endothelial 
cells 12 months after PRK surgery with mitomycin-C 
applied for 12 seconds. Diakonis et al., (32) in a 
prospective randomized study compared 15 eyes 
undergoing PRK with the use of mitomycin-C 
(0.02 %) for 15 seconds with opposite eyes from 
same patients undergoing Epi-LASIK without 
the use of mitomycin-C, 1 and 3 months after the 
surgery. No significant difference in the num-
ber of endothelial cells was observed between 
the two groups. The results of these studies are 
all consistent with our findings. In contrast, Mo-
rales et al., (22) in a prospective study performed 
on 18 eyes undergoing PRK found a significant re-
duction in corneal endothelial cells three months 
after mitomycin-C (0.02 %) usage for 30 sec-
onds. Also Nassiri et al., (23) in a non-randomized 
prospective study on 162 eye undergoing PRKI 
found a significant reduction in the number endo-
thelial of cells, six months after the surgery with 
mitomycin-C applied for 10 to 50 seconds. This 
reduction was directly related to the duration of 
mitomycin-C contact with the corneal surface. 
The duration of mitomycin-C usage in our 
study was 30 seconds and its concentration 
was (0.02 %) which indicated no significant 
change in the number of endothelial cells. This 
duration and concentration was similar to Zhao 
et al., (20) who used mitomycin-C (0.02 %) for 
15 seconds and Goldsberry et al., (21) who used 
it for 12 seconds. Most authors recommend a du-
ration of 15 to 30 seconds for mitomycin applica-
tion during LASEK and PRK surgeries (20,21).
The endothelial cell size variation coefficient showed 
a significant change in our study one year after the 
LASEK surgery using mitomycin-C. This finding is 
contrary to the results of Goldsberry etal., (21) who 
have reported no significant change 12 months af-
ter PRK surgery using mitomycin-C for 12 seconds. 
Also Zhao et al., (20) found no significant change 
in endothelial cell size variation coefficient after 
LASEK surgery using mitomycin-C for 15 seconds.
Although the lack of a control group was a limitation 
of our study, the relatively high number of participants 
and its one year followup should be considered as its 
advantages. In opinion of the authors the difference 
in results of studies on the effect of mitomycin-C 
on corneal endothelial cells might be due the 
multiplicity of variables affecting these cells, 
including the duration of mitomycin-C appli-
cation, the remaining stroma of the cornea and 
the difference in how the specular microscopy is 
performed. So in order to achieve more reliable 
results prospective studies with a control group 
and a standard time for application of mitomycin-C 
is recommended.
Conclusion
Using mitomycin - C (0, 02 % for 30 seconds) during 
the laser assisted sub-epithelial keratomileusis did 
not significantly change the corneal endothelial cell 
density one year after the surgery but the change in 
polymegathism was significant.
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